Metabolic

Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form

00

studies recruiting now

checking live

00

studies registered in total

checking live

00

countries with a recruiting site

checking live

00

recruiting study posted to date

checking live

Recruiting trials

Fetching live from ClinicalTrials.gov. This condition is not yet in our weekly snapshot; live results only.

Keep watching

Get an email when a new Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (GBE1).

Treatments being studied

4 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Phase 3Cipaglucosidase Alfa (Pombiliti)
Phase 3Alglucosidase Alfa (Myozyme)
Phase 3Avalglucosidase Alfa (Nexviadyme)
Phase 3Miglustat (Miglustat dipharma)

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).